Einseitige Implantation des SPIRION Kehlkopfschrittmachers bei Patienten mit vorheriger permanenter Glottis-Erweiterung

A randomized, double-blind study to compare efficacy, pharmacokinetics, safety, and immunogenicity between ABP 234 and Keytruda (Pembrolizumab) in subjects with advanced or metastatic non-squamous non-small cell lung cancer

A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab
versus transarterial Chemoembolization (TACE) in intermediate-stage HepatoCellular Carcinoma

Preoperative FOLFOX versus postoperativ risk-adapted chemotherapy in patients with locally advanced rectal cancer and low risk for local failure: A randomized Phase III Trial of the German Rectal Cancer Study Group.

Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin

Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/or clinically high-risk ER+/HER2- early breast cancer

Psychosoziale Unterstützungsbedarfe von Familien mit dem Li-Fraumeni-Syndrom (LFS) oder der Fanconi-Anämie (FA)

A randomized phase 3, double-blind, placebo-controlled study of elacestrant in patients with estrogen receptor - positive/ human groth factor receptor 2 negative, ESR1-mutaed, advanced breast cancer progressing to endocrine therapy and CDK 4/6 inhibitors

Comparison of two approved dialysis devices for treatment of metabolic or mixed acidosis in critically ill patients with acute kidney injury and indication for renal replacement therapy